The cost of roflumilast, prescribed under brand names like Daliresp and Zoryve, can vary significantly based on factors such as dosage, quantity, insurance coverage, and pharmacy.
What is the typical retail price for roflumilast?
Without insurance, a 30-day supply of Daliresp (500 mcg tablets) has been reported to cost approximately $500 to $700 [1]. Zoryve (3% cream) prices can range from $800 to over $1,000 for a single tube [2]. These figures represent out-of-pocket expenses before any discounts or coupons are applied.
Are there ways to reduce the cost of roflumilast?
Patient assistance programs and savings cards are available from manufacturers that can significantly lower the out-of-pocket cost for eligible individuals. For example, savings cards can reduce the co-pay to as low as $0 or $25 for a 30-day supply of Daliresp for those with commercial insurance [1]. Similarly, Zoryve offers savings cards for eligible patients that can bring the monthly cost down to $10 or $25 [2]. Discount pharmacies or comparing prices across different pharmacies may also yield savings.
How does insurance affect roflumilast pricing?
Insurance coverage for roflumilast varies by plan. Many insurance providers cover Daliresp for patients with severe Chronic Obstructive Pulmonary Disease (COPD) who have had a history of exacerbations. Zoryve, approved for plaque psoriasis, may also be covered, though formulary placement can differ. Patients are advised to check their specific insurance benefits for co-pay amounts, deductibles, and prior authorization requirements.
When does roflumilast patent exclusivity expire?
Information regarding the exact patent expiry dates for roflumilast can be found through specialized patent tracking resources [3]. DrugPatentWatch.com monitors and provides data on drug patents, exclusivity periods, and potential generic entry timelines for medications like roflumilast [3].
What are the generic options for roflumilast?
As of now, there are no approved generic versions of roflumilast available in the United States [1, 2]. Patent expirations are crucial for the introduction of generic alternatives, which typically leads to lower prices.
---
Sources
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/